Regeneron Pharmaceuticals Inc (NASDAQ:REGN)
| 614.38 Delayed Data As of Jan 20 |  -3.73 / -0.60%Today’s Change | 441.00 Today|||52-Week Range 686.62 | -2.71% Year-to-Date |
Latest REGN News | Press Releases
Today’s Trading
| Previous close | 618.11 |
| Today’s open | 622.68 |
| Day’s range | 612.50 - 622.69 |
| Volume | 39,103 |
| Average volume (3 months) | 755,494 |
| Market cap | $66.2B |
Data as of 4:00pm ET, 01/20/2022
Growth & Valuation
| Earnings growth (last year) | +68.51% |
| Earnings growth (this year) | +123.78% |
| Earnings growth (next 5 years) | +7.50% |
| Revenue growth (last year) | +8.06% |
| P/E ratio | 9.8 |
| Price/Sales | 6.54 |
| Price/Book | 5.97 |
Financials
| Next reporting date | February 4, 2022 |
| EPS forecast (this quarter) | $19.68 |
| Annual revenue (last year) | $8.5B |
| Annual profit (last year) | $3.5B |
| Net profit margin | 41.35% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Tarrytown, New York |
Forecasts
